Supplement: Fox Chase: Outfoxing Cancer

Fox Chase: Outfoxing Cancer By Kathryn Ward ARTICLE EXTRAS A Region Defined A Robust Support Infrastructure The infrastructure ECRI Laureate Pharma Quest Pharmaceutical Immunicon Morgan, Lewis & Bockius Covance Coriell Paragon Chemical InstaMed Louis Weiner Like the Greater Philadelphia region itself, Fox Chase Cancer Center has a long and impressive history. Founded in 1904 in Philadelphia as the American Oncolo

Written byKathryn Ward
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

A Region Defined

A Robust Support Infrastructure

The infrastructure

ECRI

Laureate Pharma

Quest Pharmaceutical

Immunicon

Morgan, Lewis & Bockius

Covance

Coriell

Paragon Chemical

InstaMed

Like the Greater Philadelphia region itself, Fox Chase Cancer Center has a long and impressive history. Founded in 1904 in Philadelphia as the American Oncological Hospital, Fox Chase was the nation's first cancer hospital. In 1974 it merged with the Institute for Cancer Research and became one of the first institutions to be named a National Cancer Institute Comprehensive Cancer Center.

As a Comprehensive Cancer Center, Fox Chase is one of 39 such organizations in the United States. The designation is based on outstanding laboratory and clinical facilities, as well as superior behavioral and population-based research. Besides treating patients, comprehensive cancer centers recruit subjects for early-phase clinical trials, offer outreach programs, and provide information to healthcare professionals and the public.

"Fox Chase has as its ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies